NCT02091635View on ClinicalTrials.gov

Efficacy of Motilitone on Gastric Accommodation in Healthy Adult Patients: Evaluation Using MRI Method

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
Dyspepsia
Interventions
DRUG

Placebo (for Motilitone)

Eligible subjects were randomly allocated in a 1 : 1 ratio to receive either 60 mg motilitone (motilitone group) or placebo (placebo group) three times daily (before meals) for 5 days (days 1-5).

DRUG

Motilitone

Eligible subjects were randomly allocated in a 1 : 1 ratio to receive either 60 mg motilitone (motilitone group) or placebo (placebo group) three times daily (before meals) for 5 days (days 1-5).

Trial Locations (1)

135-710

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT02091635 - Efficacy of Motilitone on Gastric Accommodation in Healthy Adult Patients: Evaluation Using MRI Method | Biotech Hunter | Biotech Hunter